Saturday, December 6, 2025

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Forced to Obey: North Korean Cabinet Orders Factories to ‘Fall in Line or Face Consequences’

North Korea's Cabinet Meeting reviewed first-quarter economic plans, emphasizing local development and the need for improved management.

Nvidia Stock Up 0.77% Despite DeepSeek’s AI Breakthrough, Still Reeling from Recent Decline

Nvidia's stock rose slightly after a decline due to competition from China's DeepSeek, raising concerns over AI chip demand.

Tag: business class

North KoreaKoreaKimSouth KoreaMilitaryAImarketchinaRussia

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.